Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.23% |
| 2 | Technology | 2.7% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Financials | 1.18% |
| 5 | Communication Services | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMI
10951
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $92.9K | ﹤0.01% |
19,227
-58,590
| -75% | -$302K |
|
10952
CALL
1-800-Flowers.com
FLWS
$240M
| $92.8K | ﹤0.01% |
11,900
-50,000
| -81% | -$459K |
|
10953
Century Casinos
CNTY
$34.6M
| $92.5K | ﹤0.01% |
13,022
-2,135
| -14% | -$15.1K |
|
|
DMK
10954
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $92.3K | ﹤0.01% |
38,600
+38,034
| +6,720% | +$162K |
|
|
MARK
10955
DELISTED
Remark Holdings, Inc.
MARK
| $92.1K | ﹤0.01% |
93,930
+1,499
| +2% | +$1.75K |
|
10956
CALL
Hyperfine
HYPR
$89.7M
| $92K | ﹤0.01% |
42,800
-6,100
| -12% | -$9.94K |
|
10957
PUT
TROOPS Inc
TROO
$269M
| $91.8K | ﹤0.01% |
+23,600
| New | +$92.3K |
|
|
VZIO
10958
PUT
DELISTED
VIZIO Holding Corp.
VZIO
| $91.8K | ﹤0.01% |
13,600
-23,700
| -64% | -$183K |
|
10959
PUT
Sportsman's Warehouse
SPWH
$44.5M
| $91.8K | ﹤0.01% |
16,100
-600
| -4% | -$3.61K |
|
|
INZY
10960
DELISTED
Inozyme Pharma
INZY
| $91.4K | ﹤0.01% |
+16,404
| New | +$97K |
|
10961
CALL
Neonode
NEON
$14.8M
| $91.3K | ﹤0.01% |
11,300
-11,400
| -50% | -$85.1K |
|
|
LEO
10962
BNY Mellon Strategic Municipals
LEO
$384M
| $91.3K | ﹤0.01% |
14,677
-7,175
| -33% | -$44.2K |
|
|
PHD
10963
DELISTED
Pioneer Floating Rate Fund
PHD
| $91.2K | ﹤0.01% |
+10,507
| New | +$90.1K |
|
10964
Nomura Holdings
NMR
$29.6B
| $91.1K | ﹤0.01% |
23,796
+2,796
| +13% | +$10.3K |
|
10965
GraniteShares Platinum Shares
PLTM
$201M
| $91K | ﹤0.01% |
10,297
-22,805
| -69% | -$228K |
|
10966
Olema Pharmaceuticals
OLMA
$944M
| $91K | ﹤0.01% |
10,072
-77,944
| -89% | -$471K |
|
10967
Edgewise Therapeutics
EWTX
$4.8B
| $90.9K | ﹤0.01% |
11,735
-5,150
| -31% | -$43.4K |
|
10968
GCM Grosvenor
GCMG
$836M
| $90.8K | ﹤0.01% |
12,048
-56,903
| -83% | -$424K |
|
|
DCF
10969
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
| $90.8K | ﹤0.01% |
+12,029
| New | +$91.5K |
|
10970
Goldgroup Mining
GORO
$511M
| $90.6K | ﹤0.01% |
143,857
-253,666
| -64% | -$225K |
|
10971
US Gold Corp
USAU
$273M
| $90.6K | ﹤0.01% |
+20,359
| New | +$89.5K |
|
10972
Deswell Industries
DSWL
$47.8M
| $90.2K | ﹤0.01% |
32,455
+2,791
| +9% | +$7.51K |
|
|
LGO
10973
PUT
Largo
LGO
$75.4M
| $90.1K | ﹤0.01% |
21,100
+1,400
| +7% | +$6.26K |
|
10974
CALL
Atossa Therapeutics
ATOS
$26.3M
| $90.1K | ﹤0.01% |
4,767
+1,900
| +66% | +$23K |
|
10975
PUT
Microvast
MVST
$296M
| $90.1K | ﹤0.01% |
56,300
+1,700
| +3% | +$2.42K |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.